#USA #Indianapolis #Securities Class Action #Berger Montague #Elevance Health

Elevance Health Investors Urged to Act Quickly

In a significant development for investors in Elevance Health, Inc. (NYSE: ELV), Berger Montague PC has announced a securities class action lawsuit filed against the company, urging affected individuals to reach out to the firm before July 11, 2025. This lawsuit centers around the period from April 18, 2024, through October 16, 2024, during which investors are believed to have experienced losses due to undisclosed issues within the company's operations.

Background of the Class Action Lawsuit

Elevance Health, based in Indianapolis, Indiana, has been a key player in the healthcare sector, offering various health insurance plans, including Medicaid benefits. However, concerns have arisen regarding the handling of Medicaid eligibility redeterminations. The class action lawsuit claims that while the company assured investors of adequate monitoring and cost control, it failed to disclose crucial information regarding rising Medicaid costs and their implications on financial forecasts.

The Allegations

According to litigation details, the class action centers on statements made by Elevance executives during the aforementioned Class Period. Despite acknowledging rising medical costs associated with Medicaid, the company maintained that its negotiations with state authorities were sufficient to cover these expenses. However, as the lawsuit claims, this was not accurately reflected in their financial outlook.

One crucial revelation occurred on July 17, 2024, when Elevance publicly acknowledged that they were anticipating an increase in Medicaid utilization for the second half of the year. This announcement led to a significant drop in the company's stock price, falling by 5.8% in response to the news.

Subsequent Financial Disclosures

The situation escalated on October 17, 2024, when Elevance reported its Q3 earnings, disclosing a shortfall in earnings per share (EPS) by $1.33, representing a staggering 13.7% miss against projections. This decline in financial performance forced the company to revise its EPS guidance for the year down from $37.20 to $33.00. Following this news, the company's stock saw another drastic decline of 10.6% in just one day.

Call to Action for Investors

Affected investors are encouraged to understand their rights within this lawsuit and to consider stepping forward as lead plaintiffs if they meet the criteria. Acting quickly is vital, as the deadline to be appointed as a lead plaintiff representative is approaching fast. Those who wish to get involved can contact Berger Montague directly to discuss their eligibility and the next steps.

About Berger Montague

Berger Montague PC is renowned in the realm of securities class action litigation, having served both individual and institutional investors for over 50 years. Their offices span across key U.S. cities, including Philadelphia, Washington D.C., and San Diego, showcasing their extensive reach within the legal landscape.

For more information about the class action or to express interest in joining the lawsuit, interested parties can reach out to senior counsel Andrews Abramowitz or Peter Hamner at the contact details provided. Remember, participation in the litigation does not hinge on taking up a lead plaintiff role; all investors may choose their own path in the process.

This class action lawsuit against Elevance Health represents a critical juncture for many investors, marking an essential opportunity for accountability and potential recovery amidst the turbulent landscape of securities investment.